DR. ELIZABETH SHAUGHNESSY, MD
Radiology in Cincinnati, OH
License number
Ohio 35-073469
Category
Radiology
Type
Surgical Oncology
Address
Address
234 Goodman St Barrett Center Ml, Cincinnati, OH 45267
Phone
(513) 584-8900
(513) 584-0459 (Fax)
(513) 245-3335
(513) 475-7259 (Fax)
(513) 584-0459 (Fax)
(513) 245-3335
(513) 475-7259 (Fax)
Personal information
See more information about ELIZABETH SHAUGHNESSY at radaris.comName
Address
Phone
5147 Lynd Ave, Cleveland, OH 44124
4033 Cherokee Trl, Brunswick, OH 44212
3339 Bishop St, Cincinnati, OH 45220
3203 Saint Mikala Ct, Twinsburg, OH 44087
8356 Summit St, Chagrin Falls, OH 44023
Organization information
See more information about ELIZABETH SHAUGHNESSY at bizstanding.comUnivervisty-Cincinnati Surgeon - Elizabeth A Shaughnessy MD
234 Goodman St #3, Cincinnati, OH 45219
Categories:
Oncology Physicians & Surgeons, Physicians & Surgeons
Site:
Phone:
(513) 584-8900 (Phone)
Products:
Military & Veteran's Services
Elizabeth Shaughnessy MD
2123 Auburn Ave, Cincinnati, OH 45219
Industry:
Surgeons
Phone:
(513) 475-8787 (Phone)
Elizabeth Ann Shaughnessy
Professional information
See more information about ELIZABETH SHAUGHNESSY at trustoria.com
Dr. Elizabeth Shaughnessy, Cincinnati OH - MD (Doctor of Medicine)
Dr. Elizabeth Shaughnessy, Cincinnati OH - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
Health Surgical Oncology
234 Goodman St, Cincinnati 45219
(513) 584-8900 (Phone)
234 Goodman St, Cincinnati 45267
(513) 584-8900 (Phone), (513) 584-0459 (Fax)
234 Goodman St, Cincinnati 45219
(513) 584-8900 (Phone)
234 Goodman St, Cincinnati 45267
(513) 584-8900 (Phone), (513) 584-0459 (Fax)
Procedures:
Biopsy of Breast, Decortication and Pleurectomy, Dressing and/or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy), Excision of Breast Tumor, Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer, Lymph Node Biopsy or Excision, Mastectomy, Port Placements or Replacements
Conditions:
Biliary Atresia, Breast Cancer, Breast Lump/Mass, Carcinoma in Situ, Colorectal Cancer, Diaphragmatic/Hiatal Hernia, Hidradenitis, Hyperparathyroidism, Lipomas, Lung Cancer, Pancreatic Cancer, Peripheral Vascular Disease (PAD, PVD), Phlebitis and Thrombophlebitis, Secondary Malignancies, Soft Tissue Sarcoma, Thyroid Cancer
Certifications:
General Surgery, 1994
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Health Surgical Oncology
234 Goodman St, Cincinnati 45219
234 Goodman St, Cincinnati 45267
University Hospital
234 Goodman St, Cincinnati 45219
234 Goodman St, Cincinnati 45219
234 Goodman St, Cincinnati 45267
University Hospital
234 Goodman St, Cincinnati 45219
Education:
Medical School
University Of Illinois College Of Medicine Chicago
Graduated: 1985
University Ill Cook Co Michael Reese Hosps
City Of Hope National Mc
University Of Illinois College Of Medicine Chicago
Graduated: 1985
University Ill Cook Co Michael Reese Hosps
City Of Hope National Mc
Grading, Staging And Prognosing Cancer Using Osteopontin-C
Grading, Staging And Prognosing Cancer Using Osteopontin-C
US Patent:
2010020, Aug 19, 2010
Filed:
Oct 16, 2008
Appl. No.:
12/682310
Inventors:
Mana Mirza - Jazan, SA
Elizabeth Shaughnessy - Cincinnati OH, US
Georg F. Weber - Cincinnati OH, US
John K. Hurley - Tucson AZ, US
Kristie A. Vanpatten - Oro Valley AZ, US
Gary Pestano - Oro Valley AZ, US
Elizabeth Shaughnessy - Cincinnati OH, US
Georg F. Weber - Cincinnati OH, US
John K. Hurley - Tucson AZ, US
Kristie A. Vanpatten - Oro Valley AZ, US
Gary Pestano - Oro Valley AZ, US
International Classification:
C12Q 1/68, C12Q 1/02, G01N 33/53
US Classification:
435 6, 435 29, 435 71
Abstract:
The present disclosure provides methods and kits that can be used to determine the grade or stage of a breast or other cancer, such as a ductal carcinoma in situ (DCIS). By determining the grade, stage, or aggressiveness of a cancer, appropriate therapeutic regiments can be selected and administered to the patient with the cancer. The method includes detecting osteopontin-c (OPN-c), wherein the presence of high amounts of OPN-c in the cancer sample indicates that the subject has a more aggressive form of cancer (e.g., grade 3).